Trandolapril (Aurobindo Pharma Limited)


Welcome to the PulseAid listing for the Trandolapril drug offered from Aurobindo Pharma Limited. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Aurobindo Pharma Limited
NON-PROPRIETARY NAME: Trandolapril
SUBSTANCE NAME: TRANDOLAPRIL
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2007-06-12
END MARKETING DATE: 0000-00-00


Trandolapril HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTrandolapril from Aurobindo Pharma Limited
LABELER NAME: Aurobindo Pharma Limited
DEA SCHEDULE:
ACTIVE STRENGTH: 1(mg/1)
START MARKETING DATE: 2007-06-12
END MARKETING DATE: 0000-00-00
PRODUCT ID: 65862-164_18eed6f4-0d6f-4d30-9e3b-ba2ba1686614
PRODUCT NDC: 65862-164
APPLICATION NUMBER: ANDA078438

Other TRANDOLAPRIL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Trandolapril
Aurobindo Pharma LimitedTrandolapril
Carilion Materials ManagementTrandolapril
Citron Pharma LLCTrandolapril
Dispensing Solutions, Inc.Trandolapril
Epic Pharma, LLCTrandolapril
Lupin Pharmaceuticals, Inc.Trandolapril
Physicians Total Care, Inc.Mavik